期刊文献+

北京市1989~2002年疫苗相关麻痹型脊髓灰质炎病例的监测 被引量:55

Surveillance of Vaccine-associated Paralytic Poliomyelitis in Beijing, 1989-2002
原文传递
导出
摘要 北京市急性弛缓性麻痹 (AFP)病例监测系统 1989~ 2 0 0 2年共诊断疫苗相关麻痹型脊髓灰质炎 (脊灰 )(VAPP) 2 0例 ,其中首次服苗VAPP 18例 ,接触服苗VAPP 2例。所有病例均 <2岁 ,<6月龄病例占 85 %。男女发病之比为 9∶1。每年VAPP发生率无明显季节性高峰和地区差异。VAPP总发生率为 1 2 0 / 10 0万剂口服脊灰减毒活疫苗 (OPV)投放量或 1 5 9/ 10 0万剂OPV接种量 ,首次服苗VAPP发生率为 13 18/ 10 0万剂首次服苗量 ,接触服苗VAPP发生率为 0 16 / 10 0万剂OPV接种量。监测结果表明 ,北京市VAPP发生的危险性高于中国其它省份和其它许多国家与地区 ;免疫缺陷和 /或肛门周围脓肿可能是VAPP重要的危险因素。在中国当前尚未改变脊灰疫苗免疫策略的情况下 ,为减少和避免VAPP的发生 ,必须加强接种前儿童病史询问和体检 ,严格掌握接种禁忌证 ;同时要加强对VAPP的监测工作。 From 1989~2002,20 cases of vaccine-associated paralytic poliomyelitis(VAPP) were identified through acute flaccid paralysis surveillance system in Beijing,18 of them were related to the first dose of OPV and 2 to the exposure of contact.All cases were under 2 years old with 85% lower than 6 months of age.The VAPP incidence ratio for male to female was 9∶1 and it had no obvious difference in months or areas each year.The overall estimated risk of VAPP was 1.20 per 1 million OPV doses distributed or 1.59 per 1 million doses administered,and with a risk of 13.18 per 1 million first doses administered for the first time recipients and a risk of 0.16 per 1 million doses administered for the contacts. The risk of VAPP in Beijing was higher than that in other provinces of China and many other countries and regions.The result also indicated that immunodeficiency and/or anal abscess probably were the important risk factors of VAPP.To reduce and aviod the occurrence of VAPP without changing current national routine immunization schedule,the information of illness history of the children must be acquired and a physical examination must be done before vaccination for children.In addition,the surveillance of VAPP needs to be strengthened.
出处 《中国计划免疫》 2003年第4期201-204,共4页 Chinese Journal of Vaccines and Immunization
关键词 北京市 疫苗 麻痹型脊髓灰质炎 病例 监测 Live attenuated oral polio vaccine:Acute flaccid paralysis(AFP) Poliomyelitis Vaccine-associated paralytic poliomyelitis
  • 相关文献

参考文献13

  • 1伍稚梅,胡家瑜,徐天强,李秀珠,赵丽丽.上海市1980~1998年口服脊髓灰质炎疫苗相关病例的流行病学分析[J].中国计划免疫,1999,5(6):321-323. 被引量:45
  • 2冯永庄,汤奋扬,周永林.江苏省1993~2000年脊髓灰质炎疫苗相关病例流行病学分析[J].中国计划免疫,2001,7(5):279-281. 被引量:38
  • 3刘桂芳,徐爱强,王海岩,刘萍,姜萍,李漫时,周晓琳,雷杰,刘尧,李岩.山东省疑似脊髓灰质炎疫苗相关病例流行病学分析[J].中国公共卫生,2001,17(9):821-823. 被引量:19
  • 4李慧,邸宏杰,何庚声,付鸿,孙延玲.甘肃省部分地区麻疹疫苗强化免疫结果分析[J].中国计划免疫,2002,8(2):82-84. 被引量:36
  • 5CDC. Paralytic poliomyelitis-United States, 1980 - 1994 [ J ]. Morb Mortal Wkly Rep, 1997, 31,46(4) :79 - 83.
  • 6de oliveira L H, Struchiner C J. Vaccine-associated paralytic poliomyelitis in Brazil, 1989 - 1995[ J ]. Rev Panam Salud Publica, 2000, 7(4) :219 - 224.
  • 7Kohler K A, Banerjee K, Gary H W, et al. Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine[J]. Bull World Health Organ, 2002;80(3):210-216.
  • 8Strebel P M, Aubert-Combieseu A, Ion-Nedelcu N, et al.Paralytic poliomyelitis in Romama, 1984 - 1992. Evidence for a high risk of vacclne-associated disease and reintroduction of wild-virus infection [J].Am J Epidemiol, 1994,140(12) :1111 - 1124.
  • 9Sutter R W, Prevots D R, Cochi S L, et al. Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States[J]. Pediatr Clin North Am, 2000,47(2) :287 - 308.
  • 10Wattigney W A, Mootrey G T, Braun M M, et al. Surveillance for poliovirus vaccine adverse events, 1991 to 1998:impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine[J]. Pediatrics, 2001, 107(5) :E83

二级参考文献8

共引文献101

同被引文献407

引证文献55

二级引证文献253

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部